▶ 調査レポート

世界の敗血症臨床検査市場(~2028年):ポイントオブケア検査、臨床検査

• 英文タイトル:Global Sepsis Clinical Testing Market Insights, Forecast to 2028

Global Sepsis Clinical Testing Market Insights, Forecast to 2028「世界の敗血症臨床検査市場(~2028年):ポイントオブケア検査、臨床検査」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-16845
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、敗血症臨床検査のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
敗血症臨床検査のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
敗血症臨床検査の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
敗血症臨床検査のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までの敗血症臨床検査の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の敗血症臨床検査の売上および2028年までの予測に焦点を当てています。

敗血症臨床検査のグローバル主要企業には、Abbott、Axis Shield、Becton Dickinson、bioMérieux、Bruker、Cytosorbents、Danaher、Immunexpress、Luminex、Mitsubishi Chemical、Response Biomedical、Roche、T2 Biosystems、Thermo Fisher Scientificなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

敗血症臨床検査市場は、タイプとアプリケーションによって区分されます。世界の敗血症臨床検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
ポイントオブケア検査、臨床検査

【アプリケーション別セグメント】
総合病院、専門クリニック

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 敗血症臨床検査製品概要
- タイプ別市場(ポイントオブケア検査、臨床検査)
- アプリケーション別市場(総合病院、専門クリニック)
- 調査の目的
・エグゼクティブサマリー
- 世界の敗血症臨床検査販売量予測2017-2028
- 世界の敗血症臨床検査売上予測2017-2028
- 敗血症臨床検査の地域別販売量
- 敗血症臨床検査の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別敗血症臨床検査販売量
- 主要メーカー別敗血症臨床検査売上
- 主要メーカー別敗血症臨床検査価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(ポイントオブケア検査、臨床検査)
- 敗血症臨床検査のタイプ別販売量
- 敗血症臨床検査のタイプ別売上
- 敗血症臨床検査のタイプ別価格
・アプリケーション別市場規模(総合病院、専門クリニック)
- 敗血症臨床検査のアプリケーション別販売量
- 敗血症臨床検査のアプリケーション別売上
- 敗血症臨床検査のアプリケーション別価格
・北米市場
- 北米の敗血症臨床検査市場規模(タイプ別、アプリケーション別)
- 主要国別の敗血症臨床検査市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの敗血症臨床検査市場規模(タイプ別、アプリケーション別)
- 主要国別の敗血症臨床検査市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の敗血症臨床検査市場規模(タイプ別、アプリケーション別)
- 主要国別の敗血症臨床検査市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の敗血症臨床検査市場規模(タイプ別、アプリケーション別)
- 主要国別の敗血症臨床検査市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの敗血症臨床検査市場規模(タイプ別、アプリケーション別)
- 主要国別の敗血症臨床検査市場規模(トルコ、サウジアラビア)
・企業情報
Abbott、Axis Shield、Becton Dickinson、bioMérieux、Bruker、Cytosorbents、Danaher、Immunexpress、Luminex、Mitsubishi Chemical、Response Biomedical、Roche、T2 Biosystems、Thermo Fisher Scientific
・産業チェーン及び販売チャネル分析
- 敗血症臨床検査の産業チェーン分析
- 敗血症臨床検査の原材料
- 敗血症臨床検査の生産プロセス
- 敗血症臨床検査の販売及びマーケティング
- 敗血症臨床検査の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 敗血症臨床検査の産業動向
- 敗血症臨床検査のマーケットドライバー
- 敗血症臨床検査の課題
- 敗血症臨床検査の阻害要因
・主な調査結果

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Sepsis Clinical Testing estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Sepsis Clinical Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Sepsis Clinical Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Sepsis Clinical Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Sepsis Clinical Testing include Abbott, Axis Shield, Becton Dickinson, bioMérieux, Bruker, Cytosorbents, Danaher, Immunexpress and Luminex, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Sepsis Clinical Testing companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Sepsis Clinical Testing market. Further, it explains the major drivers and regional dynamics of the global Sepsis Clinical Testing market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abbott
Axis Shield
Becton Dickinson
bioMérieux
Bruker
Cytosorbents
Danaher
Immunexpress
Luminex
Mitsubishi Chemical
Response Biomedical
Roche
T2 Biosystems
Thermo Fisher Scientific
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Sepsis Clinical Testing Segment by Type
Point-of-Care Testing
Laboratory Testing
Sepsis Clinical Testing Segment by Application
General Hospitals
Specialty Clinics
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Sepsis Clinical Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Sepsis Clinical Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Sepsis Clinical Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sepsis Clinical Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sepsis Clinical Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Sepsis Clinical Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Sepsis Clinical Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Axis Shield, Becton Dickinson, bioMérieux, Bruker, Cytosorbents, Danaher, Immunexpress and Luminex, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Sepsis Clinical Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sepsis Clinical Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sepsis Clinical Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Clinical Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Point-of-Care Testing
1.2.3 Laboratory Testing
1.3 Market by Application
1.3.1 Global Sepsis Clinical Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Clinical Testing Market Perspective (2017-2028)
2.2 Sepsis Clinical Testing Growth Trends by Region
2.2.1 Sepsis Clinical Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Sepsis Clinical Testing Historic Market Size by Region (2017-2022)
2.2.3 Sepsis Clinical Testing Forecasted Market Size by Region (2023-2028)
2.3 Sepsis Clinical Testing Market Dynamics
2.3.1 Sepsis Clinical Testing Industry Trends
2.3.2 Sepsis Clinical Testing Market Drivers
2.3.3 Sepsis Clinical Testing Market Challenges
2.3.4 Sepsis Clinical Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sepsis Clinical Testing Players by Revenue
3.1.1 Global Top Sepsis Clinical Testing Players by Revenue (2017-2022)
3.1.2 Global Sepsis Clinical Testing Revenue Market Share by Players (2017-2022)
3.2 Global Sepsis Clinical Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sepsis Clinical Testing Revenue
3.4 Global Sepsis Clinical Testing Market Concentration Ratio
3.4.1 Global Sepsis Clinical Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Clinical Testing Revenue in 2021
3.5 Sepsis Clinical Testing Key Players Head office and Area Served
3.6 Key Players Sepsis Clinical Testing Product Solution and Service
3.7 Date of Enter into Sepsis Clinical Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Clinical Testing Breakdown Data by Type
4.1 Global Sepsis Clinical Testing Historic Market Size by Type (2017-2022)
4.2 Global Sepsis Clinical Testing Forecasted Market Size by Type (2023-2028)
5 Sepsis Clinical Testing Breakdown Data by Application
5.1 Global Sepsis Clinical Testing Historic Market Size by Application (2017-2022)
5.2 Global Sepsis Clinical Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Sepsis Clinical Testing Market Size (2017-2028)
6.2 North America Sepsis Clinical Testing Market Size by Type
6.2.1 North America Sepsis Clinical Testing Market Size by Type (2017-2022)
6.2.2 North America Sepsis Clinical Testing Market Size by Type (2023-2028)
6.2.3 North America Sepsis Clinical Testing Market Share by Type (2017-2028)
6.3 North America Sepsis Clinical Testing Market Size by Application
6.3.1 North America Sepsis Clinical Testing Market Size by Application (2017-2022)
6.3.2 North America Sepsis Clinical Testing Market Size by Application (2023-2028)
6.3.3 North America Sepsis Clinical Testing Market Share by Application (2017-2028)
6.4 North America Sepsis Clinical Testing Market Size by Country
6.4.1 North America Sepsis Clinical Testing Market Size by Country (2017-2022)
6.4.2 North America Sepsis Clinical Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Sepsis Clinical Testing Market Size (2017-2028)
7.2 Europe Sepsis Clinical Testing Market Size by Type
7.2.1 Europe Sepsis Clinical Testing Market Size by Type (2017-2022)
7.2.2 Europe Sepsis Clinical Testing Market Size by Type (2023-2028)
7.2.3 Europe Sepsis Clinical Testing Market Share by Type (2017-2028)
7.3 Europe Sepsis Clinical Testing Market Size by Application
7.3.1 Europe Sepsis Clinical Testing Market Size by Application (2017-2022)
7.3.2 Europe Sepsis Clinical Testing Market Size by Application (2023-2028)
7.3.3 Europe Sepsis Clinical Testing Market Share by Application (2017-2028)
7.4 Europe Sepsis Clinical Testing Market Size by Country
7.4.1 Europe Sepsis Clinical Testing Market Size by Country (2017-2022)
7.4.2 Europe Sepsis Clinical Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sepsis Clinical Testing Market Size (2017-2028)
8.2 Asia-Pacific Sepsis Clinical Testing Market Size by Type
8.2.1 Asia-Pacific Sepsis Clinical Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Sepsis Clinical Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Sepsis Clinical Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Sepsis Clinical Testing Market Size by Application
8.3.1 Asia-Pacific Sepsis Clinical Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Sepsis Clinical Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Sepsis Clinical Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Sepsis Clinical Testing Market Size by Region
8.4.1 Asia-Pacific Sepsis Clinical Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Sepsis Clinical Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sepsis Clinical Testing Market Size (2017-2028)
9.2 Latin America Sepsis Clinical Testing Market Size by Type
9.2.1 Latin America Sepsis Clinical Testing Market Size by Type (2017-2022)
9.2.2 Latin America Sepsis Clinical Testing Market Size by Type (2023-2028)
9.2.3 Latin America Sepsis Clinical Testing Market Share by Type (2017-2028)
9.3 Latin America Sepsis Clinical Testing Market Size by Application
9.3.1 Latin America Sepsis Clinical Testing Market Size by Application (2017-2022)
9.3.2 Latin America Sepsis Clinical Testing Market Size by Application (2023-2028)
9.3.3 Latin America Sepsis Clinical Testing Market Share by Application (2017-2028)
9.4 Latin America Sepsis Clinical Testing Market Size by Country
9.4.1 Latin America Sepsis Clinical Testing Market Size by Country (2017-2022)
9.4.2 Latin America Sepsis Clinical Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sepsis Clinical Testing Market Size (2017-2028)
10.2 Middle East & Africa Sepsis Clinical Testing Market Size by Type
10.2.1 Middle East & Africa Sepsis Clinical Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Sepsis Clinical Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Sepsis Clinical Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Sepsis Clinical Testing Market Size by Application
10.3.1 Middle East & Africa Sepsis Clinical Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Sepsis Clinical Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Sepsis Clinical Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Sepsis Clinical Testing Market Size by Country
10.4.1 Middle East & Africa Sepsis Clinical Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Sepsis Clinical Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Sepsis Clinical Testing Introduction
11.1.4 Abbott Revenue in Sepsis Clinical Testing Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 Axis Shield
11.2.1 Axis Shield Company Details
11.2.2 Axis Shield Business Overview
11.2.3 Axis Shield Sepsis Clinical Testing Introduction
11.2.4 Axis Shield Revenue in Sepsis Clinical Testing Business (2017-2022)
11.2.5 Axis Shield Recent Developments
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Sepsis Clinical Testing Introduction
11.3.4 Becton Dickinson Revenue in Sepsis Clinical Testing Business (2017-2022)
11.3.5 Becton Dickinson Recent Developments
11.4 bioMérieux
11.4.1 bioMérieux Company Details
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Sepsis Clinical Testing Introduction
11.4.4 bioMérieux Revenue in Sepsis Clinical Testing Business (2017-2022)
11.4.5 bioMérieux Recent Developments
11.5 Bruker
11.5.1 Bruker Company Details
11.5.2 Bruker Business Overview
11.5.3 Bruker Sepsis Clinical Testing Introduction
11.5.4 Bruker Revenue in Sepsis Clinical Testing Business (2017-2022)
11.5.5 Bruker Recent Developments
11.6 Cytosorbents
11.6.1 Cytosorbents Company Details
11.6.2 Cytosorbents Business Overview
11.6.3 Cytosorbents Sepsis Clinical Testing Introduction
11.6.4 Cytosorbents Revenue in Sepsis Clinical Testing Business (2017-2022)
11.6.5 Cytosorbents Recent Developments
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher Sepsis Clinical Testing Introduction
11.7.4 Danaher Revenue in Sepsis Clinical Testing Business (2017-2022)
11.7.5 Danaher Recent Developments
11.8 Immunexpress
11.8.1 Immunexpress Company Details
11.8.2 Immunexpress Business Overview
11.8.3 Immunexpress Sepsis Clinical Testing Introduction
11.8.4 Immunexpress Revenue in Sepsis Clinical Testing Business (2017-2022)
11.8.5 Immunexpress Recent Developments
11.9 Luminex
11.9.1 Luminex Company Details
11.9.2 Luminex Business Overview
11.9.3 Luminex Sepsis Clinical Testing Introduction
11.9.4 Luminex Revenue in Sepsis Clinical Testing Business (2017-2022)
11.9.5 Luminex Recent Developments
11.10 Mitsubishi Chemical
11.10.1 Mitsubishi Chemical Company Details
11.10.2 Mitsubishi Chemical Business Overview
11.10.3 Mitsubishi Chemical Sepsis Clinical Testing Introduction
11.10.4 Mitsubishi Chemical Revenue in Sepsis Clinical Testing Business (2017-2022)
11.10.5 Mitsubishi Chemical Recent Developments
11.11 Response Biomedical
11.11.1 Response Biomedical Company Details
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Sepsis Clinical Testing Introduction
11.11.4 Response Biomedical Revenue in Sepsis Clinical Testing Business (2017-2022)
11.11.5 Response Biomedical Recent Developments
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Sepsis Clinical Testing Introduction
11.12.4 Roche Revenue in Sepsis Clinical Testing Business (2017-2022)
11.12.5 Roche Recent Developments
11.13 T2 Biosystems
11.13.1 T2 Biosystems Company Details
11.13.2 T2 Biosystems Business Overview
11.13.3 T2 Biosystems Sepsis Clinical Testing Introduction
11.13.4 T2 Biosystems Revenue in Sepsis Clinical Testing Business (2017-2022)
11.13.5 T2 Biosystems Recent Developments
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Details
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific Sepsis Clinical Testing Introduction
11.14.4 Thermo Fisher Scientific Revenue in Sepsis Clinical Testing Business (2017-2022)
11.14.5 Thermo Fisher Scientific Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer